FFCP PHASE1:Hg19::chr10:98460669..98460678,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=118788 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=30034 | |||
|TSSclassifier=strong | |||
|UniProt= | |||
|association_with_transcript=-34bp_to_ENST00000468783_5end | |||
|coexpression_cluster_id=C36 | |||
|description=CAGE_peak_9_at_PIK3AP1_5end | |||
|id=chr10:98460669..98460678,- | |||
|ontology_enrichment_celltype=CL:0000945!1.40e-37!24;CL:0000826!1.40e-37!24;CL:0000037!4.95e-25!172;CL:0000566!4.95e-25!172;CL:0000988!3.32e-23!182;CL:0002032!4.35e-23!165;CL:0000837!4.35e-23!165;CL:0000738!1.40e-21!140;CL:0002031!6.24e-20!124;CL:0000542!1.69e-19!53;CL:0000051!1.69e-19!53;CL:0002087!2.19e-19!119;CL:0000838!1.45e-17!52;CL:0000236!8.20e-11!14;CL:0000134!9.10e-08!358;CL:0002274!1.02e-07!5;CL:0000457!1.02e-07!5;CL:0002191!1.02e-07!5;CL:0000097!1.02e-07!5;CL:0000831!1.02e-07!5;CL:0002028!1.02e-07!5;CL:0000763!1.46e-07!112;CL:0000049!1.46e-07!112;CL:0002320!1.83e-07!365 | |||
|ontology_enrichment_celltype_v019=CL:0000945;2.18e-62;24!CL:0000946;5.11e-17;1!CL:0000786;5.11e-17;1!CL:0000542;7.83e-15;53!CL:0000236;4.62e-11;13!CL:0002087;2.78e-07;104 | |||
|ontology_enrichment_celltype_v019_2=CL:0000945,1.74e-62,24;CL:0000826,1.74e-62,24;CL:0000838,1.79e-28,52;CL:0000542,6.36e-28,53;CL:0000051,6.36e-28,53;CL:0002087,7.34e-18,115;CL:0000236,9.93e-18,14;CL:0002031,4.43e-17,120;CL:0000946,5.53e-17,1;CL:0000786,5.53e-17,1;CL:0000980,5.53e-17,1;CL:0000738,5.82e-15,136;CL:0002032,1.75e-12,161;CL:0000837,1.75e-12,161;CL:0000037,6.41e-12,168;CL:0000988,2.94e-11,177;CL:0000785,3.71e-09,2;CL:0000955,3.71e-09,2;CL:0000818,3.71e-09,2;CL:0000954,3.71e-09,2;CL:0000816,3.71e-09,2 | |||
|ontology_enrichment_development_v019=CL:0000051;7.83e-15;53!CL:0000954;3.57e-09;2 | |||
|ontology_enrichment_disease=DOID:0060058!1.88e-10!10;DOID:2531!4.30e-09!51;DOID:0060083!4.30e-09!51 | |||
|ontology_enrichment_disease_v019=DOID:630;1.04e-16;1!DOID:0050177;1.04e-16;1!DOID:0050427;1.04e-16;1!DOID:0060058;3.83e-07;10 | |||
|ontology_enrichment_disease_v019_2=DOID:630,1.21e-16,1;DOID:0050177,1.21e-16,1;DOID:0050427,1.21e-16,1;DOID:0060058,3.77e-07,10 | |||
|ontology_enrichment_uberon=UBERON:0002106!6.56e-13!3;UBERON:0004854!6.56e-13!3;UBERON:0009034!6.56e-13!3;UBERON:0002095!6.56e-13!3;UBERON:0004782!6.56e-13!3;UBERON:0003281!6.56e-13!3;UBERON:0009664!6.56e-13!3;UBERON:0002296!6.56e-13!3;UBERON:0005602!6.56e-13!3;UBERON:0001179!6.56e-13!3;UBERON:0006293!6.56e-13!3;UBERON:0002390!1.04e-08!102;UBERON:0003061!1.04e-08!102;UBERON:0002193!1.13e-08!112;UBERON:0002384!4.72e-07!375 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.2857764471619,3.44822475689772,2.91229890860613,0,0,0,0,0,0,0.697204805222715,2.55904618477359,0,0.553995408531877,0.601633342410425,0.868043482863407,0,0,0,0,0.377875943688809,0,0,0,0,0,0,0,0,0,0,0,0,0.224723484445085,0,0.641858054152187,0,0,0,0,0,1.13477044938228,0,0,0,0,0,1.10483290796269,0.316462387440884,0,0,0,0,0,0,0,0,0,0,0,0,0,1.60158394814405,0,0.661044872784862,0.954053754535364,0,1.17447437874188,1.91136614062614,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0654895377488563,0,0,0,0,0,0,0,0.74291500265913,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.621984346622316,0.144119953416961,0.12624243342638,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.197030760201927,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206768026122887,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.238231775457789,0.411362273086194,0,0,0,0,0,0,0.371606350251437,0,0,0,0.199579371432817,0,0.211673582723883,0,0,0,0,0,0,0.481764225311099,0.403599414382095,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.276283915531148,0,0,1.84627208191604,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.31396051279005,0.166211681900156,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0969890164884194,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0846733320657845,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.365377795142688,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.23658523500376,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.37889152711961,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0939839179798536,0.193373663920732,4.59729317254673,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.673520530145875,0.143444410785353,0,0,0,0,0,0,0,0,0,0.402547587182052,2.24397944612263 | |||
|short_description=p9@PIK3AP1 | |||
}} |
Revision as of 04:23, 11 January 2014
Short description: | p9@PIK3AP1 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_9_at_PIK3AP1_5end |
Coexpression cluster: | C36_B_b_splenic_plasma_xeroderma_adrenal_Burkitt |
Association with transcript: | -34bp_to_ENST00000468783_5end |
EntrezGene: | PIK3AP1 |
HGNC: | 30034 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
lymphocyte of B lineage | 1.74e-62 | 24 |
pro-B cell | 1.74e-62 | 24 |
lymphoid lineage restricted progenitor cell | 1.79e-28 | 52 |
lymphocyte | 6.36e-28 | 53 |
common lymphoid progenitor | 6.36e-28 | 53 |
nongranular leukocyte | 7.34e-18 | 115 |
B cell | 9.93e-18 | 14 |
hematopoietic lineage restricted progenitor cell | 4.43e-17 | 120 |
antibody secreting cell | 5.53e-17 | 1 |
plasma cell | 5.53e-17 | 1 |
plasmablast | 5.53e-17 | 1 |
leukocyte | 5.82e-15 | 136 |
hematopoietic oligopotent progenitor cell | 1.75e-12 | 161 |
hematopoietic multipotent progenitor cell | 1.75e-12 | 161 |
hematopoietic stem cell | 6.41e-12 | 168 |
hematopoietic cell | 2.94e-11 | 177 |
mature B cell | 3.71e-09 | 2 |
pre-B-II cell | 3.71e-09 | 2 |
transitional stage B cell | 3.71e-09 | 2 |
small pre-B-II cell | 3.71e-09 | 2 |
immature B cell | 3.71e-09 | 2 |
Ontology term | p-value | n |
---|---|---|
genetic disease | 1.21e-16 | 1 |
monogenic disease | 1.21e-16 | 1 |
xeroderma pigmentosum | 1.21e-16 | 1 |
lymphoma | 3.77e-07 | 10 |